Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Terminated 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Breast Neoplasms 251Lymphoma 241Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Leukemia 178Lymphoma, Large B-Cell, Diffuse 167Multiple Myeloma 166Lymphoma, Non-Hodgkin 155Leukemia, Lymphocytic, Chronic, B-Cell 146Leukemia, Myeloid, Acute 136Myelodysplastic Syndromes 116Hodgkin Disease 115Lymphoma, Follicular 113Burkitt Lymphoma 108Lymphoma, Mantle-Cell 104Lymphoma, B-Cell, Marginal Zone 76Lymphoma, Large-Cell, Immunoblastic 64Neoplasms, Plasma Cell 59Recurrence 58Leukemia, Myelogenous, Chronic, BCR-ABL Positive 57Myeloproliferative Disorders 53Neoplasms 49Leukemia, Myeloid, Chronic-Phase 49Triple Negative Breast Neoplasms 47Leukemia, Myeloid, Accelerated Phase 47Melanoma 46Leukemia, Myelomonocytic, Chronic 46Dendritic Cell Sarcoma, Interdigitating 46Waldenstrom Macroglobulinemia 42Hematologic Neoplasms 41Congenital Abnormalities 39

Interventions

Ipilimumab 10pembrolizumab 7Nivolumab 7incomplete Freund's adjuvant 6Temozolomide 5Dacarbazine 5tebentafusp 4Sunitinib 4MART-1 Antigen 4Carboplatin 4CTLA-4 Antigen 4sargramostim 3montanide ISA 51 3aflibercept 3Paclitaxel 3Bevacizumab 3trametinib 2relatlimab 2olaparib 2lenvatinib 2cediranib 2Vorinostat 2Thalidomide 2Taxes 2Sorafenib 2Radiosurgery 2MAGEA3 protein, human 2Lenalidomide 2Interleukin-2 2Interleukin-12 Subunit p35 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Uveal Melanoma × Cyclophosphamide × Clear all
NCT01814046 2018-10-11

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
24 enrolled 13 charts
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

NCT00482911 2017-03-27

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 10 charts
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡